trial

Virtual Reality for Visual Perception on Schizophrenia

NCTId NCT06718556
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 57 (actual)
Sponsored by Saglik Bilimleri Universitesi
Primary completion 2024-06-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
57 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2023-06-01
Primary completion
2024-06-01
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Virtual realityClient-centered

Sponsors

Saglik Bilimleri UniversitesiLead Sponsor

Sites

1 total
Ankara, Turkey (Türkiye)

Facts & assertions

4 sourced
Enrollment
57
Phase
NA
Primary Completion Date
2024-06-01
Status
COMPLETED
relationships
The graph out of here
drug
Virtual reality
drug
Client-centered
drug
lead_sponsor
Saglik Bilimleri Universitesi
company
indication
Schizophrenia
indication
Schizophenia Disorder
indication
Visual Perception
indication